Antibody feedback limits the expansion of cognate memory B cells but drives the diversification of vaccine-induced antibody responses
McNamara, H. A.; Idris, A. H.; Sutton, H. J.; Flynn, B. J.; Cai, Y.; Wiehe, K.; Lyke, K. E.; Chatterjee, D.; KC, N.; Chakravarty, S.; Sim, K. L.; Hoffman, S. L.; Bonsignori, M.; Seder, R. A.; Cockburn, I. A.
Show abstract
Generating sufficient antibody to block infection is a key challenge for vaccines against malaria. Here we show that antibody titres to a key target, the repeat region of the Plasmodium falciparum circumsporozoite protein (PfCSP), plateaued after two immunizations in a clinical trial of the radiation-attenuated sporozoite vaccine. To understand the mechanisms limiting vaccine responsiveness, we developed Ig-knockin mice with elevated numbers of PfCSP-binding B cells. We determined that recall responses were inhibited by antibody feedback via epitope masking of the immunodominant PfCSP repeat region. Importantly, the amount of antibody that prevents boosting is below the amount of antibody required for protection. Finally, while antibody feedback limited responses to the PfCSP-repeat region in vaccinated volunteers, potentially protective subdominant responses to C-terminal regions did expand with subsequent boosts. These data suggest that antibody feedback drives the diversification of immune responses and that vaccination for malaria will require the targeting of multiple antigens.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling 97%
- Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine 96%
- Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex 96%
Similar papers in this journal
- An Epitope-based Malaria Vaccine Targeting the Junctional Domain of Circumsporozoite Protein 96%
- A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses 96%
- Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naive human B cells 96%
Similar papers in this journal
- Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination 97%
- Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccination 96%
- Quality of vaccination-induced T cell responses is conveyed by polyclonality and high, but not maximum, antigen receptor avidity 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.